Unknown

Dataset Information

0

Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.


ABSTRACT:

Background

The processes that result in progression of idiopathic pulmonary fibrosis (IPF) remain enigmatic. Moreover, the course of this disease can be highly variable and difficult to accurately predict. We hypothesized analyses of body mass index (BMI), a simple, routine clinical measure, may also have prognostic value in these patients, and might provide mechanistic insights. We investigated the associations of BMI changes with outcome, plasma adipokines, and adaptive immune activation among IPF patients.

Methods

Data were analyzed in an IPF discovery cohort (n = 131) from the University of Pittsburgh, and findings confirmed in patients from the University of Alabama at Birmingham (n = 148). Plasma adipokines were measured by ELISA and T-cell phenotypes determined by flow cytometry.

Results

Transplant-free one-year survivals in subjects with the greatest rates of BMI decrements, as percentages of initial BMI (>0.68%/month), were worse than among those with more stable BMI in both discovery (HR = 1.8, 95%CI = 1.1-3.2, p = 0.038) and replication cohorts (HR = 2.5, 95%CI = 1.2-5.2, p = 0.02), when adjusted for age, baseline BMI, and pulmonary function. BMI decrements >0.68%/month were also associated with greater mortality after later lung transplantations (HR = 4.6, 95%CI = 1.7-12.5, p = 0.003). Circulating leptin and adiponectin levels correlated with BMI, but neither adipokine was prognostic per se. BMI decrements were significantly associated with increased proportions of circulating end-differentiated (CD28null) CD4 T-cells (CD28%), a validated marker of repetitive T-cell activation and IPF prognoses.

Conclusions

IPF patients with greatest BMI decrements had worse outcomes, and this effect persisted after lung transplantation. Weight loss in these patients is a harbinger of poor prognoses, and may reflect an underlying systemic process, such as adaptive immune activation.

SUBMITTER: Kulkarni T 

PROVIDER: S-EPMC6777779 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.

Kulkarni Tejaswini T   Yuan Kaiyu K   Tran-Nguyen Thi K TK   Kim Young-Il YI   de Andrade Joao A JA   Luckhardt Tracy T   Valentine Vincent G VG   Kass Daniel J DJ   Duncan Steven R SR  

PloS one 20191004 10


<h4>Background</h4>The processes that result in progression of idiopathic pulmonary fibrosis (IPF) remain enigmatic. Moreover, the course of this disease can be highly variable and difficult to accurately predict. We hypothesized analyses of body mass index (BMI), a simple, routine clinical measure, may also have prognostic value in these patients, and might provide mechanistic insights. We investigated the associations of BMI changes with outcome, plasma adipokines, and adaptive immune activati  ...[more]

Similar Datasets

| S-EPMC10836485 | biostudies-literature
| S-EPMC9866551 | biostudies-literature
| S-EPMC8448817 | biostudies-literature
| S-EPMC3425334 | biostudies-other
| S-EPMC5639928 | biostudies-literature
| S-EPMC8559550 | biostudies-literature
| S-EPMC5563167 | biostudies-literature
| S-EPMC8575586 | biostudies-literature
| S-EPMC7258421 | biostudies-literature
| S-EPMC6906546 | biostudies-literature